Zivo Bioscience, Inc.
ZIVO
$17.80
-$0.10-0.56%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 31.50K | -- | 35.70K | 11.80K | 11.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.50K | -- | 35.70K | 11.80K | 11.80K |
| Cost of Revenue | 22.10K | -- | 23.20K | 7.70K | 7.70K |
| Gross Profit | 9.50K | -- | 12.50K | 4.10K | 4.10K |
| SG&A Expenses | 1.94M | 5.98M | 975.60K | 1.59M | 1.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.29M | 8.23M | 1.31M | 1.91M | 1.58M |
| Operating Income | -2.26M | -8.23M | -1.28M | -1.90M | -1.57M |
| Income Before Tax | -2.27M | -8.24M | -1.28M | -1.91M | -1.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.27M | -8.24M | -1.28M | -1.91M | -1.82M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.27M | -8.24M | -1.28M | -1.91M | -1.82M |
| EBIT | -2.26M | -8.23M | -1.28M | -1.90M | -1.57M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.67 | -2.78 | -0.47 | -0.99 | -1.05 |
| Normalized Basic EPS | -0.42 | -1.74 | -0.29 | -0.62 | -0.66 |
| EPS Diluted | -0.67 | -2.78 | -0.47 | -0.99 | -1.05 |
| Normalized Diluted EPS | -0.42 | -1.74 | -0.29 | -0.62 | -0.66 |
| Average Basic Shares Outstanding | 3.41M | 2.96M | 2.75M | 1.93M | 1.74M |
| Average Diluted Shares Outstanding | 3.41M | 2.96M | 2.75M | 1.93M | 1.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
